Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Identification of metabolites reproducibly associated with Parkinson’s Disease via meta-analysis and computational modelling

Article in npj Parkinson's Disease (June 2024)

Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial

Article in Pharmacological Research (May 2024)

Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights

Article in Frontiers of Medicine (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.